ES2421719T3 - Antígeno de gliadina recombinante desamidada - Google Patents

Antígeno de gliadina recombinante desamidada

Info

Publication number
ES2421719T3
ES2421719T3 ES09734340T ES09734340T ES2421719T3 ES 2421719 T3 ES2421719 T3 ES 2421719T3 ES 09734340 T ES09734340 T ES 09734340T ES 09734340 T ES09734340 T ES 09734340T ES 2421719 T3 ES2421719 T3 ES 2421719T3
Authority
ES
Spain
Prior art keywords
deamidated
recombinant gliadin
recombinant
antigen
gliadin antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES09734340T
Other languages
English (en)
Inventor
Michael Watkins
Gregory Marr
Xiaoyun Yang
Richard Bruehl
Daming Shan
Patrick Coleman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bio Rad Laboratories Inc
Original Assignee
Bio Rad Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Rad Laboratories Inc filed Critical Bio Rad Laboratories Inc
Application granted granted Critical
Publication of ES2421719T3 publication Critical patent/ES2421719T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/104—Aminoacyltransferases (2.3.2)
    • C12N9/1044—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/23—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a GST-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/415—Assays involving biological materials from specific organisms or of a specific nature from plants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/91045—Acyltransferases (2.3)
    • G01N2333/91074—Aminoacyltransferases (general) (2.3.2)
    • G01N2333/9108—Aminoacyltransferases (general) (2.3.2) with definite EC number (2.3.2.-)
    • G01N2333/91085—Transglutaminases; Factor XIIIq (2.3.2.13)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Cell Biology (AREA)
  • Rehabilitation Therapy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Botany (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Un antígeno para detectar la enfermedad celíaca, que comprende una gliadina recombinante desamidada quecomprende un dímero o trímero de SEC ID NO:1, en el que la gliadina recombinante desamidada está unidacovalentemente a una etiqueta formando una proteína de fusión de gliadina, en la que la etiqueta está inmovilizadasobre un soporte sólido.
ES09734340T 2008-04-21 2009-04-17 Antígeno de gliadina recombinante desamidada Active ES2421719T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4669308P 2008-04-21 2008-04-21
PCT/US2009/040943 WO2009131909A2 (en) 2008-04-21 2009-04-17 Recombinant deamidated gliadin antigen

Publications (1)

Publication Number Publication Date
ES2421719T3 true ES2421719T3 (es) 2013-09-05

Family

ID=41217372

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09734340T Active ES2421719T3 (es) 2008-04-21 2009-04-17 Antígeno de gliadina recombinante desamidada

Country Status (7)

Country Link
US (2) US20090311727A1 (es)
EP (2) EP2659901B1 (es)
JP (2) JP5694916B2 (es)
AU (1) AU2009239558B2 (es)
CA (1) CA2721582C (es)
ES (1) ES2421719T3 (es)
WO (1) WO2009131909A2 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8680019B2 (en) 2007-08-10 2014-03-25 Protelica, Inc. Universal fibronectin Type III binding-domain libraries
US8470966B2 (en) 2007-08-10 2013-06-25 Protelica, Inc. Universal fibronectin type III binding-domain libraries
WO2009023184A2 (en) 2007-08-10 2009-02-19 Protelix, Inc. Universal fibronectin type iii binding-domain libraries
AU2009239558B2 (en) * 2008-04-21 2013-05-02 Bio-Rad Laboratories, Inc. Recombinant deamidated gliadin antigen
HUE027237T2 (en) 2008-11-30 2016-10-28 Immusant Inc Preparations and methods for treating celiac disease
CA2798995A1 (en) * 2010-03-10 2011-09-15 IMMCO Diagnostics, Inc. Compositions and methods for determining celiac disease
WO2012019157A2 (en) * 2010-08-06 2012-02-09 The Regents Of The University Of California Expression and purification of fusion protein with multiple mbp tags
AU2012348122B2 (en) 2011-12-05 2017-09-14 Bio-Rad Laboratories, Inc. Recombinant deamidated gliadin antigen
JP6012767B2 (ja) 2012-02-07 2016-10-25 ヴィブラント ホールディングス リミテッド ライアビリティ カンパニー 基板、ペプチドアレイ、および方法
US10006909B2 (en) 2012-09-28 2018-06-26 Vibrant Holdings, Llc Methods, systems, and arrays for biomolecular analysis
US10286376B2 (en) 2012-11-14 2019-05-14 Vibrant Holdings, Llc Substrates, systems, and methods for array synthesis and biomolecular analysis
CA3177975A1 (en) 2013-02-15 2014-08-21 Vibrant Holdings, Llc Methods and compositions for amplified electrochemiluminescence detection
AU2014318889B2 (en) 2013-09-10 2020-02-20 Immusant, Inc. Dosage of a gluten peptide composition
ES2465715B1 (es) * 2014-02-14 2015-03-18 Universitat Autónoma De Barcelona Péptido, péptido magnético y método para detectar la enfermedad celíaca
CA2962933A1 (en) 2014-09-29 2016-04-07 Immusant, Inc. Use of hla genetic status to assess or select treatment of celiac disease
US10782285B2 (en) 2014-10-03 2020-09-22 Rite Taste, LLC Device and method for chemical analysis
CA2963464C (en) * 2014-10-03 2024-02-27 Rite Taste, LLC Device and method for chemical analysis
WO2018148801A1 (en) * 2017-02-15 2018-08-23 University Of Technology Sydney Nanoparticles adsorbed with gliadin molecules
WO2018218250A2 (en) 2017-05-26 2018-11-29 Vibrant Holdings, Llc Photoactive compounds and methods for biomolecule detection and sequencing
US11209416B2 (en) 2017-07-28 2021-12-28 Graphene-Dx, Inc. Device and method for chemical analysis
WO2019148167A1 (en) 2018-01-29 2019-08-01 Rite Taste, LLC Methods and devices for detection of pathogens

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5260203A (en) 1986-09-02 1993-11-09 Enzon, Inc. Single polypeptide chain binding molecules
WO1996003652A1 (de) * 1994-07-25 1996-02-08 Boehringer Mannheim Gmbh Bestimmung von spezifischem immunglobulin unter verwendung multipler antigene
US5770380A (en) 1996-09-13 1998-06-23 University Of Pittsburgh Synthetic antibody mimics--multiple peptide loops attached to a molecular scaffold
US6207370B1 (en) * 1997-09-02 2001-03-27 Sequenom, Inc. Diagnostics based on mass spectrometric detection of translated target polypeptides
US7115396B2 (en) 1998-12-10 2006-10-03 Compound Therapeutics, Inc. Protein scaffolds for antibody mimics and other binding proteins
US6818418B1 (en) 1998-12-10 2004-11-16 Compound Therapeutics, Inc. Protein scaffolds for antibody mimics and other binding proteins
WO2002083722A2 (en) * 2001-04-12 2002-10-24 Academisch Ziekenhuis Leiden Methods and means for use of hla-dq restricted t-cell receptors and hla-dq-binding prolamine-derived peptides
US20040023848A1 (en) * 2002-02-27 2004-02-05 Thomas Boehm Compositions for the treatment, prevention, and diagnosis of gastrointestinal and other infections
US7265093B2 (en) * 2002-05-14 2007-09-04 The Board Of Trustees Of The Leland Stanford Junior University Drug therapy for Celiac Sprue
US7462688B2 (en) * 2002-05-14 2008-12-09 The Board Of Trustees Of The Leland Stanford Junior University Peptides for diagnostic and therapeutic methods for celiac sprue
ES2383595T3 (es) * 2002-11-20 2012-06-22 The Board Of Trustees Of The Leland Stanford Junior University Procedimiento de diagnóstico de la celiaquía
US20080038760A1 (en) * 2004-06-08 2008-02-14 Method For Decting Anti-Transglutaminase Antibodies Method for Detecting Anti-Transglutaminase Antibodies
KR20080082629A (ko) * 2005-11-10 2008-09-11 리셉터 바이오로직스 인크 간세포 성장인자 인트론 융합 단백질
DE102007025291A1 (de) * 2007-05-30 2008-12-04 Euroimmun Ag Verfahren und Immunabsorbentien zur spezifischen Detektion und Absorption Zöliakie- und Dermatitis herpetiformis assoziierter Antikörper
US20090176251A1 (en) * 2008-01-08 2009-07-09 Binder Walter L Methods for Diagnosing Celiac Disease Based on the Level of Anti-Gliadin and Anti-tTG IgA and IgG Antibodies
AU2009239558B2 (en) * 2008-04-21 2013-05-02 Bio-Rad Laboratories, Inc. Recombinant deamidated gliadin antigen

Also Published As

Publication number Publication date
EP2659901A1 (en) 2013-11-06
JP2011521898A (ja) 2011-07-28
US20170146531A1 (en) 2017-05-25
CA2721582C (en) 2017-07-11
US20090311727A1 (en) 2009-12-17
EP2276499A4 (en) 2012-02-08
JP6073940B2 (ja) 2017-02-01
JP5694916B2 (ja) 2015-04-01
EP2276499A2 (en) 2011-01-26
AU2009239558B2 (en) 2013-05-02
CA2721582A1 (en) 2009-10-29
AU2009239558A1 (en) 2009-10-29
WO2009131909A2 (en) 2009-10-29
WO2009131909A3 (en) 2010-01-07
EP2276499B1 (en) 2013-06-12
JP2015091878A (ja) 2015-05-14
EP2659901B1 (en) 2015-01-21

Similar Documents

Publication Publication Date Title
ES2421719T3 (es) Antígeno de gliadina recombinante desamidada
ES2570731T3 (es) Método de detección de cáncer
ES2530777T3 (es) Vacunas peptídicas para cánceres que expresan antígenos asociados a tumores
ES2616658T3 (es) Péptidos que mimetizan el factor de crecimiento y sus usos
CU24058B1 (es) Antagonistas de pcsk9
PE20120532A1 (es) ANTICUERPOS ANTI-ActRIIB
AR074857A1 (es) Proteinas de union al receptor cgrp (peptidos relacionados con el gen de calcitonina) humano
PE20091004A1 (es) Proteinas de union a antigenos c-fms humanos
CR10652A (es) Anticuerpos monoclonales humanos especificos para light humano antagonistas
ES2685823T3 (es) Anticuerpos antagonistas anti-CD40
PE20100738A1 (es) Anticuerpos humanos de alta afinidad para el receptor il-4 humano
PE20150023A1 (es) Proteinas de union a antigeno st2
BRPI1006443A2 (pt) proteína ou peptídeo de fusão de meia-vida aumentada in vivo mantidos por liberação sustentada in vivo, e método para aumentar a meia-vida in vivo usando os mesmos.
PE20121616A1 (es) Anticuerpos anti-her3
CL2013003416A1 (es) Secuencia de peptidos quiméricos que comprende dsspl o dasph composiciones , usos y metodo para mejorar metabolismo de glucosa.
AR083747A1 (es) Anticuerpos anti-il-23
CR11504A (es) Deteccion mejorada de la expresion de mage-a
ES2585480T3 (es) Anticuerpo anti-NR10 y uso del mismo
ES2571879T3 (es) Moléculas de una sola cadena de TNFSF
EA201000327A1 (ru) Белок
AR113492A2 (es) Furina recombinante libre de proteínas sustancialmente animal y métodos para producirla
NZ598770A (en) Monoclonal antibodies
ES2585328T3 (es) Variantes no lipidadas de antígenos ORF2086 de Neisseria meningitidis
ES2531385T3 (es) Formulación que comprende un anticuerpo contra la selectina P
CY1120055T1 (el) Αντικαρκινικη πρωτεϊνη συντηξης